Oesophageal cancer, Stomach cancer
Results
Phase 2
This trial looked at lapatinib with chemotherapy for cancer of the food pipe (oesophagus) and the stomach that have tested positive to a protein called HER2.
People that took part had lapatinib and chemotherapy before surgery to try to shrink the cancer. This is called .
Recruitment start: 17 June 2011
Recruitment end: 16 November 2013
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Hugo Ford
Cambridge University Hospitals NHS Foundation Trust
Experimental Cancer Medicine Centre (ECMC)
GlaxoSmithKline
Medical Research Council
NIHR Clinical Research Network: Cancer
Last reviewed: 11 December 2017
CRUK internal database number: 8475
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
